Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Girma

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Biochimie|January 1, 1974
Preparation of iodo derivatives and high specific activity 3H synthetic human gastrin IJ P Girma, J L Morgat, P Fromageot, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)A Veyradier, J-M Lavergne, A-S Ribba, et al.
The New England Journal of Medicine|February 11, 1982
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimersH J Weiss, D Meyer, R Rabinowitz, et al.
FEBS Letters|July 15, 1976
Interaction of 3H-labelled synthetic human gastrin I with rat gastric plasma membranes. Evidence for the existence of biologically reactive gastrin receptor sitesM Lewin, A Soumarmon, J P Bali, et al.
Blood|May 1, 1986
Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodiesJ P Girma, M Kalafatis, G Piétu, et al.
Journal of Thrombosis and Haemostasis : JTH|November 8, 2006
Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13J Rayes, A Hommais, P Legendre, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|April 1, 1994
Interaction of von Willebrand factor with platelets activated by thrombin or a synthetic 7-amino acid peptide derived from the cleaved thrombin receptorO Minckes, J M Freyssinet, C Rouault, et al.
Thrombosis and Haemostasis|January 1, 1997
Abnormal proteolytic processing of von Willebrand factor Arg611 Cys and Arg611HisT Nishikubo, O Christophe, J M Lavergne, et al.
Thrombosis and Haemostasis|October 5, 2001
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagenA S Ribba, I Loisel, J M Lavergne, et al.
Blood|June 15, 1994
Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factorO Christophe, A S Ribba, D Baruch, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Biochimie|January 1, 1974
Preparation of iodo derivatives and high specific activity 3H synthetic human gastrin IJ P Girma, J L Morgat, P Fromageot, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)A Veyradier, J-M Lavergne, A-S Ribba, et al.
The New England Journal of Medicine|February 11, 1982
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimersH J Weiss, D Meyer, R Rabinowitz, et al.
FEBS Letters|July 15, 1976
Interaction of 3H-labelled synthetic human gastrin I with rat gastric plasma membranes. Evidence for the existence of biologically reactive gastrin receptor sitesM Lewin, A Soumarmon, J P Bali, et al.
Blood|May 1, 1986
Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodiesJ P Girma, M Kalafatis, G Piétu, et al.
Journal of Thrombosis and Haemostasis : JTH|November 8, 2006
Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13J Rayes, A Hommais, P Legendre, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|April 1, 1994
Interaction of von Willebrand factor with platelets activated by thrombin or a synthetic 7-amino acid peptide derived from the cleaved thrombin receptorO Minckes, J M Freyssinet, C Rouault, et al.
Thrombosis and Haemostasis|January 1, 1997
Abnormal proteolytic processing of von Willebrand factor Arg611 Cys and Arg611HisT Nishikubo, O Christophe, J M Lavergne, et al.
Thrombosis and Haemostasis|October 5, 2001
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagenA S Ribba, I Loisel, J M Lavergne, et al.
Blood|June 15, 1994
Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factorO Christophe, A S Ribba, D Baruch, et al.
Pageof 7